Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock,$0.001 par value per share
- Shares outstanding
- 72,096,078
- Total 13F shares
- 44,437,538
- Share change
- +1,444,477
- Total reported value
- $2,050,628,439
- Put/Call ratio
- 28%
- Price per share
- $46.14
- Number of holders
- 123
- Value change
- +$49,057,461
- Number of buys
- 59
- Number of sells
- 71
Report period
Q1 2022
Institutions
123
Top holders
10
ZNTL full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98943L107
Recent filing periods:
Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9.4%
|
6,795,831
|
$571,257,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.1%
|
4,382,881
|
$368,425,000 | — | 31 Dec 2021 | |
| Matrix Capital Management Company, LP |
13F
|
Company |
6%
|
4,349,279
|
$365,600,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
3,186,986
|
$267,898,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.9%
|
2,842,945
|
$238,978,000 | — | 31 Dec 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
3.8%
|
2,715,000
|
$228,223,000 | — | 31 Dec 2021 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.6%
|
2,628,409
|
$220,944,000 | — | 31 Dec 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.9%
|
2,118,284
|
$178,063,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
1,346,416
|
$113,180,000 | — | 31 Dec 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.7%
|
1,253,640
|
$105,381,000 | — | 31 Dec 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.4%
|
974,660
|
$81,929,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
926,937
|
$77,918,000 | — | 31 Dec 2021 | |
| Capital World Investors |
13F
|
Company |
0.95%
|
683,000
|
$57,413,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.92%
|
661,211
|
$55,581,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.83%
|
599,636
|
$50,405,000 | — | 31 Dec 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
529,000
|
$44,468,000 | — | 31 Dec 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.6%
|
430,544
|
$36,192,000 | — | 31 Dec 2021 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.58%
|
418,792
|
$35,202,000 | — | 31 Dec 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.51%
|
369,329
|
$31,046,000 | — | 31 Dec 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.51%
|
368,324
|
$30,961,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.51%
|
368,173
|
$30,949,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
349,765
|
$29,401,000 | — | 31 Dec 2021 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.42%
|
300,434
|
$25,254,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
261,006
|
$21,941,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.3%
|
219,115
|
$18,419,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.27%
|
197,388
|
$16,592,000 | — | 31 Dec 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.27%
|
191,140
|
$16,067,000 | — | 31 Dec 2021 | |
| Holocene Advisors, LP |
13F
|
Company |
0.26%
|
190,251
|
$15,992,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.21%
|
152,445
|
$12,815,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
143,628
|
$12,073,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
141,369
|
$11,883,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.19%
|
137,584
|
$11,565,311 | — | 31 Dec 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.19%
|
136,226
|
$11,451,000 | — | 31 Dec 2021 | |
| AXA S.A. |
13F
|
Company |
0.19%
|
133,392
|
$11,213,000 | — | 31 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.18%
|
129,980
|
$10,925,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
120,656
|
$8,599,000 | — | 31 Dec 2021 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.17%
|
120,000
|
$10,087,000 | — | 31 Dec 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
117,633
|
$9,888,000 | — | 31 Dec 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.16%
|
117,500
|
$9,877,000 | — | 31 Dec 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.16%
|
117,352
|
$9,865,000 | — | 31 Dec 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
84,912
|
$7,138,000 | — | 31 Dec 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.12%
|
83,526
|
$7,021,000 | — | 31 Dec 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.11%
|
80,000
|
$6,725,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
66,800
|
$5,615,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
65,199
|
$5,481,000 | — | 31 Dec 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.09%
|
63,163
|
$5,309,482 | — | 31 Dec 2021 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.09%
|
62,711
|
$5,271,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
61,664
|
$5,184,000 | — | 31 Dec 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.08%
|
59,264
|
$4,980,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
0.07%
|
53,783
|
$4,521,000 | — | 31 Dec 2021 |
Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q1 2022
As of 31 Mar 2022,
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,437,538 shares.
The largest 10 holders included
FMR LLC, Matrix Capital Management Company, LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Avidity Partners Management LP, BlackRock Inc., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, and PRIMECAP MANAGEMENT CO/CA/.
This page lists
123
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
134
Q1 2022 holders
123
Holder diff
-11
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.